Toxicity, antitumour and haematological effects of 1,2-anhydro-6-bromogalactitol and d-mannitol: A comparison with the related dibromo- and dianhydro-derivatives-Reference-Cited by-同舟云学术

Toxicity, antitumour and haematological effects of 1,2-anhydro-6-bromogalactitol and d-mannitol: A comparison with the related dibromo- and dianhydro-derivatives

Published:1982-06 Issue:6 Volume:18 Page:573-577
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Horváth I.P.,Somfai-Relle S.,Hegedüs L.,Jarman M.

Publisher

Elsevier BV

Subject

Oncology

Reference17 articles.

1. Effect of 1,6-dibromo-1,6-dideoxy-d-mannitol on chronic granulocytic leukemia;Eckhardt;Cancer Chemother Rep,1963

2. Survival of chronic myeloid leukaemia patients treated by dibromomannitol;Eur J Cancer,1963

3. Clinical and pharmacologic experience with dibromodulcitol (NSC-104 800), a new antitumor agent;Sellei;Cancer Chemother Rep,1969

4. Phase I study of dibromodulcitol (NSC 104 800);Andrews;Cancer Chemother Rep,1971

5. Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man. 1. Metabolites of DBD;Horváth;Eur J Cancer,1979

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COMMON VEHICLES FOR THE NONCLINICAL EVALUATION OF THERAPEUTIC AGENTS;Drug Safety Evaluation;2022-12-23

2. APPENDIX E: COMMON VEHICLES FOR THE NONCLINICAL EVALUATION OF THERAPEUTIC AGENTS;Drug Safety Evaluation;2017-01-03

3. Tolerable Levels of Nonclinical Vehicles and Formulations Used in Studies by Multiple Routes in Multiple Species With Notes on Methods to Improve Utility;International Journal of Toxicology;2016-01-10

4. Alkylating Agents;Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures;2010-11-03

5. Nonclinical Vehicle Use in Studies by Multiple Routes in Multiple Species;International Journal of Toxicology;2006-11